Reiter's syndrome after intravesical Bacillus Calmette-Guérin treatment for superficial bladder carcinoma.
A 64-year-old woman developed acute Reiter's syndrome 4 weeks after the start of intravesical Bacillus Calmette-Guérin immunotherapy for a recurrent superficial bladder carcinoma. The absence of any other cause suggests that the bacillus played an etiopathogenic role in this HLA-B27-positive patient.
Pancaldi
P
P
Department of Rheumatology, Community Hospital, La Chaux-de-Fonds.
Van Linthoudt
D
D
Alborino
D
D
Haefliger
J M
JM
Ott
H
H
D016918:Arthritis, Reactive / Q000209:etiology*; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D002277:Carcinoma / Q000628:therapy*; D005260:Female; D006801:Humans; D007267:Injections; D008875:Middle Aged; D001743:Urinary Bladder; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine